Active Stocks
Sat Feb 01 2025 15:29:55
  1. ITC share price
  2. 461.00 3.01%
  1. Tata Steel share price
  2. 133.10 -1.15%
  1. Tata Motors share price
  2. 706.45 -1.33%
  1. NTPC share price
  2. 318.10 -1.90%
  1. Power Grid Corporation Of India share price
  2. 290.65 -3.71%
Business News/Market/Market Stats/    Suven Pharmaceuticals

SUVEN PHARMACEUTICALS SUMMARY

Suven Pharmaceuticals is trading 4.59% upper at Rs 1104.00 as compared to its last closing price. Suven Pharmaceuticals has been trading in the price range of 1146.15 & 1046. Suven Pharmaceuticals has given -8.86% in this year & 0.18% in the last 5 days.

 

Suven Pharmaceuticals has TTM P/E ratio 122.75 as compared to the sector P/E of 28.24. There are 1 analysts who have initiated coverage on Suven Pharmaceuticals. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.

 

The company posted a net profit of 82.21 Crores in its last quarter.

 

Listed peers of Suven Pharmaceuticals include Syngene International (-1.1%), JB Chemicals & Pharmaceuticals (0.1%), Suven Pharmaceuticals (4.59%) etc.

 

Suven Pharmaceuticals has a 50.1% promoter holding & 49.9% public holding.

FAQs about Suven Pharmaceuticals

Suven Pharmaceuticals is trading at 1104.00 as on 1 Feb, 2025 3:29:57 PM. This is 4.59% upper as compared to its previous closing price of 1055.55
The market capitalization of Suven Pharmaceuticals is 26421.3 Cr as on 1 Feb, 2025 3:29:57 PM.
The average broker rating on Suven Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -
  • 0.00 analysts have given a strong sell rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a hold rating
  • 0.00 analysts have given a buy rating
  • 1 analysts have given a strong buy rating
The 52 wk high for Suven Pharmaceuticals is 1359 whereas the 52 wk low is 586.10
Suven Pharmaceuticals can be analyzed on the following key metrics -
  • TTM P/E: 122.75
  • Sector P/E: 28.24
  • Dividend Yield: 0%
  • D/E ratio: -
Suven Pharmaceuticals reported a net profit of 300.28 Cr in 2024.
Recommended For You